Relapse With Rituximab More Common in Severe Pemphigus
Medscape,
NEW YORK (Reuters Health) - Pemphigus patients with severe disease and those with persistent anti-desmoglein (DSG) antibodies…
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy
Overview of attention for article published in JAMA Dermatology, May 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (82nd percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 63 Mendeley